SEC Form 4 · accession 0001652917-16-000011
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel P Van Plew
Officer — EVP & General Mgr Industrial O
Period of report
May 17, 2016
Accepted (ET)
May 19, 2016 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 17, 2016 | M | 9,460 | $30.63 | A | 11,381 | D | |
| Common Stock | May 17, 2016 | F | 746 | $388.14 | D | 10,635 | D | |
| Common Stock | May 17, 2016 | F | 4,301 | $388.14 | D | 6,334 | D | |
| Common StockF1 | May 18, 2016 | S | 4,413 | $385.77 | D | 1,921 | D | |
| Common Stock | holding | — | — | — | 18,705 | I | by GRAT | |
| Common Stock | holding | — | — | — | 1,444 | I | By 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $30.63 | May 17, 2016 | M | 9,460 | D | — | Dec 14, 2020 | Common Stock | 9,460 | 32,735 | D |
Explanation of responses
- F1Represents volume-weighted average price of sales of 4,413 shares of Company stock on May 18, 2016 at prices ranging from $385.66 to $385.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 18, 2016 at each separate price.
- F2The option became exercisable with respect to all shares underlying the option on December 31, 2013, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2013.